| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 09/08/2010 | EP2225366A1 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 09/08/2010 | EP1521839B1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 09/08/2010 | CN1754002B Compositions concerning poxviruses and cancer and its preparation method |
| 09/08/2010 | CN101822844A Tumor targeted molecular chemotherapeutic gene-virus preparation SG500-dNKmut and construction method and applications |
| 09/08/2010 | CN101475641B Adenovirus vector avian influenza recombinant vaccine |
| 09/08/2010 | CN101376878B Pig propagation and breathing syndrome virus stain, and inactivated vaccine prepared thereby |
| 09/08/2010 | CN101182494B Gene VII type new castle disease virus weakening strain A-NDV-VII and construction method thereof |
| 09/07/2010 | US7790449 Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor |
| 09/07/2010 | US7790434 Methods and compositions for expressing negative-sense viral RNA in canine cells |
| 09/07/2010 | US7790419 Antiviral vectors |
| 09/07/2010 | US7790181 Vaccine preparations comprise full-length cDNA copies of the EEE genome which has been altered such that the RNA produced from the cDNA, and the virus produced there from is attenuated and useful as a live vaccine for human and veterinary use |
| 09/07/2010 | US7790180 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790179 Attenuated rotavirus population comprising a single variant or substantially a single variant which is defined by a nucleotide sequence encoding at least one of the major viral proteins designated as VP4 and VP7; diarrhea therapy |
| 09/07/2010 | US7790177 Immunizing compositions comprising recombinant attenuated self-replicating viral RNA replicons encoding an epitope obtained from the HIV-1 matrix protein myrstate binding site |
| 09/07/2010 | US7790169 Modified calciviral capsid for use in prevention and treatment of respiratory disorders in cats; veterinary medicine |
| 09/07/2010 | US7790154 DNA viral plasmid for use as gene transfer tool in genetic engineering and genic therapy; improved exogenous transcriptional expression |
| 09/07/2010 | CA2608864C Recombinant mva virus, and the use thereof |
| 09/07/2010 | CA2596274C Recombinant mva virus, and the use thereof |
| 09/02/2010 | WO2010099414A2 Protection of human corneal endothelial against cell death under storage conditions by anti-apoptotic genes |
| 09/02/2010 | WO2009139921A3 Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
| 09/02/2010 | US20100221820 Use of triplex structure DNA in transferring nucleotide sequences |
| 09/02/2010 | US20100221811 Recombinant adenovirus useful for treating malignancy over-expressing proto-oncogene neu/erb b2 |
| 09/02/2010 | US20100221281 High molecular weight polysaccharide that binds and inhibits virus |
| 09/02/2010 | US20100221264 Inhibition of HIV-1 Replication by Disruption of the Processing of the Viral Capsid-Spacer Peptide 1 Protein |
| 09/02/2010 | US20100221242 Anti-viral griffithsin compounds, compositions and methods of use |
| 09/02/2010 | US20100221228 y134.5 Deficient HSV and the MAPK Pathway |
| 09/02/2010 | US20100221215 Linked dibenzimidazole derivatives |
| 09/01/2010 | EP2224006A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
| 09/01/2010 | EP2224001A1 Improved epitope displaying phage |
| 09/01/2010 | EP2223933A1 Genes encoding major capsid protein l1 of human papilloma viruses |
| 09/01/2010 | EP1833508B1 Porcine reproductive and respiratory syndrome virus strains and compositions |
| 09/01/2010 | EP1549672B1 Ablated slam-dependent cell entry |
| 09/01/2010 | EP1427815B1 Methods for the industrial production of vaccines |
| 09/01/2010 | CN101820905A Recombinant koi herpesvirus (KHV) or cyprinid herpesvirus 3 (CyHV-3) and vaccine for the prevention of disease caused by KHV/CyHV-3 in cyprinus carpio carpio or cyprinus carpio koi |
| 09/01/2010 | CN101818163A Recombined adenovirus expressing Asia-1 foot-and-mouth disease virus VLP (Virus-like Particles) and application thereof |
| 09/01/2010 | CN101818133A VSIG4 (V-set and Ig domain containing 4) and IGRP (glucose-6-phosphatase catalytic subunit-related protein) dual-gene coexpression recombinant adenovirus as well as preparation method and application thereof |
| 09/01/2010 | CN101818132A Construction of chimeric rabies strain rLEP333Q-L(H) and research on biological function thereof |
| 09/01/2010 | CN101818131A Production method for influenza virus vaccines |
| 09/01/2010 | CN101818130A gG and TK gene-deleted recombinant infectious bovine rhinotracheitis virus and application |
| 09/01/2010 | CN101817091A Method for preparing iron nano-magnetic particles by taking T4 phage as template |
| 09/01/2010 | CN101816786A Inactivated hepatitis A vaccine and preparation method thereof |
| 08/31/2010 | US7786288 A binding site of the cystosolic protein cyclophilin A on human immunodeficiency virus capsid protein, which may be expressed by a recombinant viral, bacterial or yeast carrier; may be treated with neuraminidase or trypsin to remove sialic acid; immune stimulant such as teichoic acid or zymosan |
| 08/31/2010 | US7786287 Hepatitis C virus assay systems |
| 08/31/2010 | US7786047 an immunoglobulin having determined antigen specificity, and having a variable fragment which is derived from a so-called heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding one or several antigens and which is further naturally devoid of light chains |
| 08/31/2010 | US7785888 Adeno-associated viral vector for use as heterologous gene transfer agent |
| 08/31/2010 | US7785887 Which effect p53 binding/inactivation; enhances efficacy of such viruses for treating cancer; liposomes |
| 08/31/2010 | US7785873 Antigen arrays for treatment of bone disease |
| 08/31/2010 | US7785870 Cell-specific expression/replication vector |
| 08/31/2010 | US7785859 Methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 08/31/2010 | US7785773 an immunographic device comprising a porous membrane connected to to a sample portion, a test portion comprising an immunoglobulin antibody binding agent, a control portion, a suction portion, a virus portion and a conjugate portion and instructions for analyzing or monitoring a viral infection |
| 08/31/2010 | US7785611 comprising a liquid solution consisting of an immunogenic substance and magnesium carbonate hydroxide pentahydrate, used for generating an immune response |
| 08/31/2010 | US7785604 nine residue peptides (ApoptoM) from flavivirus M ectodomain able to modulate specifically the apoptotic activity of diverse flavivirus; use for the treatment and/or the prevention of flavivirus-linked infections and cancers |
| 08/31/2010 | US7785602 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus |
| 08/31/2010 | US7785586 Capable of binding with a wild type HBsAg antigen and with at least one, preferably at least two or more, mutated forms of the HBsAg antigen |
| 08/31/2010 | CA2336472C Negative-sense rna virus vector for nerve cell |
| 08/31/2010 | CA2262010C Hsv strain lacking functional icp27 and icp34.5 genes |
| 08/26/2010 | WO2010096249A2 Solenopsis invicta virus |
| 08/26/2010 | WO2010094976A1 Novel use of polymers |
| 08/26/2010 | WO2010074575A3 Recombinant classical swine fever virus (csfv) comprising a modified e2 protein and methods for generating said recombinant csfv. |
| 08/26/2010 | US20100216651 Viral polyhedra complexes and methods of use |
| 08/26/2010 | US20100215696 Efficiently replicable heptitis c virus mutant, a heptitis c virus mutant comprising reporter gene, a method of preparing of hcv vaccine using the same and a method of screening anti hcv composition using the same |
| 08/26/2010 | US20100215693 Immunological herpes simplex virus antigens and methods for use thereof |
| 08/26/2010 | US20100215692 Dengue Chimeric Viruses |
| 08/26/2010 | US20100215691 Recombinant viral vectors |
| 08/26/2010 | US20100215682 Deletion of the beta 20-21 loop in hiv gp120 exposes the cd4 binding site for improved antibody binding and antibody induction |
| 08/26/2010 | US20100215675 Replikin-based compounds for prevention and treatment of influenza and methods of differentiating infectivity and lethality in influenza |
| 08/26/2010 | US20100215621 Recombinant Adenoviruses Capable Of Regulating Angiogenesis |
| 08/25/2010 | EP2221361A2 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| 08/25/2010 | EP2220241A2 Simian e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38 |
| 08/25/2010 | EP2220217A2 Simian subfamily c adenoviruses sadv-40, -31, and-34 and uses thereof |
| 08/25/2010 | EP1194580B2 In vitro reconstitution of segmented negative-strand rna viruses |
| 08/25/2010 | CN1871518B Method of detecting hepatitis c virus |
| 08/25/2010 | CN101015691B Recombinant phages influenza vaccine |
| 08/24/2010 | US7781642 Animal model having a chimeric human liver and susceptible to human hepatitis C virus infection |
| 08/24/2010 | US7781210 Natural killer cell line for use as tool in elucidation of mechanism of oncogenesis; identifying modulator for treatment of cell proliferative disorders |
| 08/24/2010 | US7780962 Insertion of viruse genes into cells; administering interferon sensitivity Rna virus; antitumor agents, anticancer agents |
| 08/24/2010 | CA2431639C Using viruses to detect or purify proteins |
| 08/24/2010 | CA2374140C Improved storage and maintenance of blood products including red blood cells and platelets |
| 08/19/2010 | US20100210563 Metastasis-specific peptides and their diagnostic and therapeutic applications |
| 08/19/2010 | US20100209455 Thermal inactivation of rotavirus |
| 08/19/2010 | US20100209454 Attenuated viruses useful for vaccines |
| 08/19/2010 | US20100209395 Solenopsis invicta virus |
| 08/19/2010 | US20100209393 Use of Polynucleotides Encoding Small Acid-Soluble Spore Protein for Inhibiting Bacterial Cell Growth and/or Treating Bacterial Infections |
| 08/19/2010 | US20100209392 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 08/19/2010 | US20100209349 Phage Therapy Against Pseudomonas Aeruginosa |
| 08/18/2010 | EP2218776A1 Animal protein-free media for cultivation of cells |
| 08/18/2010 | EP2218775A1 Method for producing a polypeptide in vitro in mammalian cells in a protein-free and serum-free culture medium |
| 08/18/2010 | EP2217699A2 Respiratory syncytial virus vaccine based on chimeric papillomavirus virus-like particles or capsomeres |
| 08/18/2010 | EP1636352B1 Improvements in virus production |
| 08/18/2010 | CN101809144A Method for producing flu virus |
| 08/18/2010 | CN101808657A Stabilization of vaccines by lyophilization |
| 08/18/2010 | CN101805724A Targeting WWOX (WW domain-containing oxidoreductase) gene recombinant adenovirus and preparation method and application thereof |
| 08/18/2010 | CN101338303B Adenovirus marked by radionuclide |
| 08/18/2010 | CN101235363B Pig transmissible gastroenteritis virus vaccine strain and application thereof |
| 08/18/2010 | CN101168743B Recombination baculoviral and its preparation method and application |
| 08/17/2010 | US7776598 Methods and compositions for polypeptide engineering |
| 08/17/2010 | US7776580 isolating a target cell, cellular organelle or virus from a sample using inter alia, non- or low-specific binding between a target cell, cellular organelle or virus with a magnetic microbead |
| 08/17/2010 | US7776523 assaying a sample comprising prostate cells, an RNA comprising a Gag or Pol encoding sequence of a human endogenous mouse mammary tumor virus (MMTV)-like subgroup 2 (HML-2) retrovirus, HERV-K (CH) |
| 08/17/2010 | US7776322 infectious adenovirus viral vector particle comprising an adenovirus capsid Fiber protein; use of these viral vector particles as a therapeutic, prophylactic or diagnostic means in humans and primates as well as other vertebrates like cattle, pigs, birds, fish, or rodents |
| 08/17/2010 | CA2271955C Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses |